TranS1, Inc. (TSON)


TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease affecting the lower lumbar region of the spine. TranS1 currently markets two single-level fusion products, the AxiaLIF(r) and the AxiaLIF 360(tm), in the U.S. and Europe. In addition the company currently markets a two-level fusion product, the AxiaLIF 2L(tm), in Europe. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit

Contact Information

411 Landmark Drive
Wilmington, NC 28412-6303

tel: 910-332-1700
fax: 910-332-1701


Investor Relations



Exchange: NASDAQ
Industry: Medical Instruments & Supplies
Market Cap: $275.3M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.